-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on ORIC Pharmaceuticals, Maintains $26 Price Target

Benzinga·11/17/2026 12:07:21
Listen to the news
BTIG analyst Jeet Mukherjee reiterates ORIC Pharmaceuticals (NASDAQ:ORIC) with a Buy and maintains $26 price target.